Physiological and clinical outcomes associated with fluid bolus therapy administered at rapid response calls for hypotension; a retrospective observational study

Administration of intravenous fluid bolus (FB) is a ubiquitous treatment strategy for hypotension in hospitalised patients. While accepted as standard care, there is limited evidence of its benefit and injudicious FB administration may be harmful. We aimed to evaluate current practice, physiological response and clinical outcomes associated with administration of FB to hypotensive patients during Rapid Response Team (RRT) review.